Kendall Capital Partners is a Boston-based venture capital firm investing in U.S. life sciences and healthcare companies from early to commercial stages. It focuses on biotechnology, pharmaceuticals, medical devices, healthtech, AI-enabled care, computational biology, gene and cell therapies, immunotherapies, advanced drug delivery, and scalable infrastructure. The firm backs scientifically rigorous founders and academic spinouts, with Series A activity across U.S. healthcare and life sciences startups.